Eugenia Gianos

2.6k total citations · 2 hit papers
72 papers, 1.1k citations indexed

About

Eugenia Gianos is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eugenia Gianos has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 20 papers in Surgery and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eugenia Gianos's work include Lipoproteins and Cardiovascular Health (16 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Pharmacology and Obesity Treatment (6 papers). Eugenia Gianos is often cited by papers focused on Lipoproteins and Cardiovascular Health (16 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Pharmacology and Obesity Treatment (6 papers). Eugenia Gianos collaborates with scholars based in United States, France and United Kingdom. Eugenia Gianos's co-authors include Arthur Schwartzbard, Howard Weintraub, Stacey E. Rosen, Nanette K. Wenger, Mary Rosser, Martha Gulati, Alexandria J. Hill, John J. Warner, Lisa M. Hollier and Haywood L. Brown and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Eugenia Gianos

62 papers receiving 1.1k citations

Hit Papers

Nutritional priorities to support GLP-1 therapy for obesi... 2025 2026 2025 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugenia Gianos United States 19 461 238 152 145 131 72 1.1k
Teresa N. Harrison United States 21 501 1.1× 186 0.8× 237 1.6× 114 0.8× 121 0.9× 79 1.5k
Valérie Olié France 16 444 1.0× 81 0.3× 152 1.0× 186 1.3× 110 0.8× 106 1.1k
Pierre‐Olivier Blotière France 14 255 0.6× 187 0.8× 259 1.7× 85 0.6× 53 0.4× 23 1.1k
Arnaud D. Kazé United States 21 313 0.7× 284 1.2× 152 1.0× 314 2.2× 66 0.5× 62 1.6k
Géric Maura France 14 444 1.0× 138 0.6× 118 0.8× 71 0.5× 33 0.3× 28 1.2k
Oluseye Ogunmoroti United States 19 868 1.9× 118 0.5× 353 2.3× 164 1.1× 59 0.5× 76 1.5k
Tracy Wolff United States 15 219 0.5× 127 0.5× 206 1.4× 31 0.2× 72 0.5× 30 1.0k
Lucie Opatrny Canada 14 190 0.4× 158 0.7× 118 0.8× 54 0.4× 104 0.8× 28 938
Chih‐Chia Liang Taiwan 21 133 0.3× 191 0.8× 84 0.6× 76 0.5× 213 1.6× 52 1.2k
Leonid Barski Israel 17 256 0.6× 340 1.4× 46 0.3× 333 2.3× 22 0.2× 64 1.2k

Countries citing papers authored by Eugenia Gianos

Since Specialization
Citations

This map shows the geographic impact of Eugenia Gianos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenia Gianos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenia Gianos more than expected).

Fields of papers citing papers by Eugenia Gianos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenia Gianos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenia Gianos. The network helps show where Eugenia Gianos may publish in the future.

Co-authorship network of co-authors of Eugenia Gianos

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenia Gianos. A scholar is included among the top collaborators of Eugenia Gianos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenia Gianos. Eugenia Gianos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parikh, Nisha I., et al.. (2025). Gender differences in lipid management, LDL-C goal attainment, and prescribing practices. Journal of clinical lipidology. 20(2). 438–443.
2.
Vaidean, Georgeta, et al.. (2025). Trends in lipoprotein(a) testing and impact on clinical care: A contemporary systemwide analysis. American Journal of Preventive Cardiology. 25. 101402–101402.
4.
Vaidean, Georgeta, et al.. (2024). Traditional and non-traditional cardiovascular risk factor profiles in young patients with coronary artery disease. SHILAP Revista de lepidopterología. 47. 100471–100471.
5.
Szema, Anthony M., et al.. (2024). Life-Threatening Reaction to Lifesaving Medication. JACC Case Reports. 29(19). 102614–102614.
6.
Gianos, Eugenia, et al.. (2024). A Patient who is Nonresponsive to PSCK9 Inhibition by both mAb and RNAi. Journal of clinical lipidology. 18(4). e507–e507.
7.
Pavlovic, Maia, et al.. (2024). *Pericardial and Pleural Effusions after Evolocumab in a Patient with Severe Familial Hypercholesterolemia. Journal of clinical lipidology. 18(4). e506–e507.
8.
Agarwala, Anandita, Dave L. Dixon, Eugenia Gianos, et al.. (2024). Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association. Journal of clinical lipidology. 18(5). e664–e684. 14 indexed citations
9.
Zhu, Jianhui, Floyd Thoma, Oscar C. Marroquin, et al.. (2024). Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults. SHILAP Revista de lepidopterología. 18. 100664–100664. 2 indexed citations
10.
Fishbein, Joanna, et al.. (2023). Clinical, Sociodemographic, and Neighborhood Characteristics Associated with Adverse Pregnancy Outcomes. Journal of Women s Health. 33(3). 308–317. 2 indexed citations
11.
Gianos, Eugenia, Emily S. Lau, Samar R. El Khoudary, & John R. Guyton. (2023). JCL Roundtable: Lipidology and Women's Health. Journal of clinical lipidology. 17(1). 4–11. 3 indexed citations
12.
Eid, Marwen, et al.. (2022). The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review. SHILAP Revista de lepidopterología. 13. 100173–100173. 26 indexed citations
13.
Spyropoulos, Alex C., Stuart L. Cohen, Eugenia Gianos, et al.. (2021). Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19. Research and Practice in Thrombosis and Haemostasis. 5(2). 296–300. 27 indexed citations
14.
Giannis, Dimitrios, Matthew A. Barish, Mark Goldin, et al.. (2021). Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19. Journal of Thrombosis and Thrombolysis. 51(4). 897–901. 30 indexed citations
15.
Goldin, Mark, Nina Kohn, Michael Qiu, et al.. (2021). External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19. Journal of Thrombosis and Thrombolysis. 52(4). 1032–1035. 25 indexed citations
17.
Smilowitz, Nathaniel R., et al.. (2017). Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction. Coronary Artery Disease. 29(1). 46–52. 41 indexed citations
18.
Weintraub, Howard, Steven H. Lamm, James Underberg, et al.. (2016). Cardiovascular Effects of the New Weight Loss Agents. Journal of the American College of Cardiology. 68(8). 849–859. 19 indexed citations
19.
Berger, Jeffrey S., et al.. (2015). DIET AND THE PREVENTION OF CARDIOVASCULAR DISEASE: PHYSICIANS’ KNOWLEDGE, ATTITUDES, AND PRACTICES. Journal of the American College of Cardiology. 65(10). A1447–A1447.
20.
Singh, Amita, Arthur Schwartzbard, Eugenia Gianos, Jeffrey S. Berger, & Howard Weintraub. (2012). What should we do about Hypertriglyceridemia in Coronary Artery Disease Patients?. Current Treatment Options in Cardiovascular Medicine. 15(1). 104–117. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026